FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1808253393> ?p ?o ?g. }

• W1808253393 abstract "Insulin resistance is the central feature of a variety of metabolic disorders, such as type 2 diabetes and the metabolic syndrome. The incidence of these disorders, often together with obesity, is currently increasing throughout the world. Insulin resistance occurs together with obesity, but also when adipose tissue is absent, indicating an important role of normal adipose tissue function for the maintenance of insulin sensitivity. Also, an accumulation of fat in the liver is observed together with both the excess and the absence of adipose tissue and insulin resistance. The interplay between the metabolic disturbances in adipose tissue and accumulation of fat in the liver which may underlie the development of insulin resistance is not well understood. Therefore, the aim of this thesis is to improve our knowledge of the molecular pathways underlying metabolic disturbances in adipose tissue and hepatic fat accumulation as well as the interplay between them in order to better understand the development of insulin resistance and related disorders in man. Twenty type 2 diabetes patients were treated with either rosiglitazone (an insulin sensitizer, an agonist of the transcription factor PPAR , which is predominantly expressed in adipose tissue) or metformin (an insulin sensitizer believed to act mainly in the liver). Rosiglitazone decreased liver fat content in these patients, while metformin did not. Biopsies from subcutaneous adipose tissue were taken before and after 16 weeks of treatment. Expression of 50 genes previously shown to be altered by TZDs in experimental models was measured. We found that rosiglitazone, but not metformin treatment, increased expression of genes involved in fatty acid synthesis and storage and in glucose uptake and decreased some macrophage and inflammation markers. This suggests that together with an improvement in insulin sensitivity and a decrease in liver fat content, rosiglitazone increases lipid storage and decreases inflammation within subcutaneous adipose tissue. In order to investigate changes in the liver when it becomes fatty, we analyzed gene expression in liver biopsies from 24 subjects with histologically determined liver fat content ranging from normal (n=8) to non-alcoholic hepatic steatosis (n=16). We found that expression of genes involved in fatty acid storage and inflammation was grater in livers of subjects with high liver fat content, indicating an alteration of hepatic gene expression towards an adipogenic and inflammatory profile upon excess fat accumulation. Next, we investigated whether adipose tissue is inflamed in subjects with increased liver fat content independently of the degree of obesity. Twenty obese, but otherwise healthy women with a wide range of liver fat contents were recruited and divided in normal liver fat (n=10) and high liver fat (n=10) groups. Biopsies from subcutaneous adipose tissue were analyzed by quantitative PCR, immunohistochemistry and lipidomic analysis. Expression of inflammatory markers was higher in the adipose tissue of women with high liver fat. Immunohistochemical analysis revealed increased macrophage infiltration in adipose tissue of women with high liver fat. These macrophages were mostly found surrounding dead adipocytes. Lipidomic analysis showed higher concentrations of long-chain TGs and some sphingomyelins and ceramides in the adipose tissue of women with high liver fat. In order to investigate the increase in ceramides in the inflamed adipose tissue of women with high liver fat content, we characterized ceramide metabolism within adipose tissue. Gene expression analysis suggested that the increase in ceramide might be explained by an increase in sphingomyelin hydrolysis by sphingomyelinases, especially by SMPD3, rather than by de novo synthesis of ceramide. Sphingomyelinases were expressed by both adipocytes and macrophages, but strongest expression was found in and around blood vessels within adipose tissue. In summary, the work contained in this thesis demonstrates the importance of inflammation in adipose tissue and liver and the degree of hepatic fat accumulation, but not the degree of obesity per se, in the development of insulin resistance. Sphingomyelinmediated ceramide production, which shares some features with the process of atherosclerosis, offers a link between the accumulation of fat in the liver and the development of inflammation in adipose tissue. LIST OF PUBLICATIONS I. Maria Kolak, Hannele Yki-Jarvinen, Katja Kannisto, Mirja Tiikkainen, Anders Hamsten, Per Eriksson, Rachel M. Fisher. Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism,2007, 92:720-724 II. Jukka Westerbacka, Maria Kolak, Tuula Kiviluoto, Perttu Arkkila, Jukka Siren, Anders Hamsten, Rachel M. Fisher and Hannele Yki-Jarvinen. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes, 2007, 56:2759-2765 III. Maria Kolak, Jukka Westerbacka, Vidya R. Velagapudi, Dick Wagsater, Laxman Yetukuri, Janne Makkonen, Aila Rissanen, Anna-Maija Hakkinen, Monica Lindell, Robert Bergholm, Anders Hamsten, Per Eriksson, Rachel M. Fisher, Matej Oresi , and Hannele Yki-Jarvinen. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes, 2007, 56:1960-1968 IV. Maria Kolak, Jukka Westerbacka, Anders Hamsten, Scott A. Summers, Anders Franco-Cereceda, Jan Liska, Matej Oresi , Hannele Yki-Jarvinen, Per Eriksson, Rachel M Fisher. Characterization of altered ceramide metabolism in inflamed adipose tissue. Manuscript." @default.
• W1808253393 created "2016-06-24" @default.
• W1808253393 creator A5077345674 @default.
• W1808253393 date "2008-11-07" @default.
• W1808253393 modified "2023-09-27" @default.
• W1808253393 title "Adipose tissue inflammation, hepatic fat accumulation and insulin resistance" @default.
• W1808253393 cites W126726363 @default.
• W1808253393 cites W1531859756 @default.
• W1808253393 cites W1552214119 @default.
• W1808253393 cites W1555300211 @default.
• W1808253393 cites W1555673341 @default.
• W1808253393 cites W1607230014 @default.
• W1808253393 cites W1673084462 @default.
• W1808253393 cites W1675830194 @default.
• W1808253393 cites W1782165729 @default.
• W1808253393 cites W1849396925 @default.
• W1808253393 cites W1963828400 @default.
• W1808253393 cites W1966452335 @default.
• W1808253393 cites W1969233134 @default.
• W1808253393 cites W1971452427 @default.
• W1808253393 cites W1971983445 @default.
• W1808253393 cites W1972317154 @default.
• W1808253393 cites W1972482953 @default.
• W1808253393 cites W1972709924 @default.
• W1808253393 cites W1972809949 @default.
• W1808253393 cites W1973833585 @default.
• W1808253393 cites W1974436444 @default.
• W1808253393 cites W1974599416 @default.
• W1808253393 cites W1975418306 @default.
• W1808253393 cites W1977188464 @default.
• W1808253393 cites W1978937087 @default.
• W1808253393 cites W1979101494 @default.
• W1808253393 cites W1979999470 @default.
• W1808253393 cites W1981833670 @default.
• W1808253393 cites W1984077928 @default.
• W1808253393 cites W1984413737 @default.
• W1808253393 cites W1986131332 @default.
• W1808253393 cites W1991079474 @default.
• W1808253393 cites W1991760464 @default.
• W1808253393 cites W1993959456 @default.
• W1808253393 cites W1995000970 @default.
• W1808253393 cites W1995126002 @default.
• W1808253393 cites W1995290986 @default.
• W1808253393 cites W1997661967 @default.
• W1808253393 cites W1998493448 @default.
• W1808253393 cites W1998962160 @default.
• W1808253393 cites W1999177710 @default.
• W1808253393 cites W1999229158 @default.
• W1808253393 cites W2000054651 @default.
• W1808253393 cites W2004861205 @default.
• W1808253393 cites W2006639171 @default.
• W1808253393 cites W2007194743 @default.
• W1808253393 cites W2008869160 @default.
• W1808253393 cites W2009170266 @default.
• W1808253393 cites W2010763118 @default.
• W1808253393 cites W2011067202 @default.
• W1808253393 cites W2011556186 @default.
• W1808253393 cites W2011730239 @default.
• W1808253393 cites W2012295774 @default.
• W1808253393 cites W2012898950 @default.
• W1808253393 cites W2016617561 @default.
• W1808253393 cites W2017769599 @default.
• W1808253393 cites W2018358662 @default.
• W1808253393 cites W2018926746 @default.
• W1808253393 cites W2018991404 @default.
• W1808253393 cites W2019973807 @default.
• W1808253393 cites W2020372377 @default.
• W1808253393 cites W2021946345 @default.
• W1808253393 cites W2022048961 @default.
• W1808253393 cites W2022930571 @default.
• W1808253393 cites W2023459898 @default.
• W1808253393 cites W2025607561 @default.
• W1808253393 cites W2027065577 @default.
• W1808253393 cites W2027874598 @default.
• W1808253393 cites W2028225825 @default.
• W1808253393 cites W2030065542 @default.
• W1808253393 cites W2031020280 @default.
• W1808253393 cites W2031364639 @default.
• W1808253393 cites W2033421880 @default.
• W1808253393 cites W2035339090 @default.
• W1808253393 cites W2035536340 @default.
• W1808253393 cites W2038689279 @default.
• W1808253393 cites W2040109162 @default.
• W1808253393 cites W2040358658 @default.
• W1808253393 cites W2041600649 @default.
• W1808253393 cites W2041767551 @default.
• W1808253393 cites W2043253461 @default.
• W1808253393 cites W2044569784 @default.
• W1808253393 cites W2046731226 @default.
• W1808253393 cites W2046933787 @default.
• W1808253393 cites W2046994269 @default.
• W1808253393 cites W2047740187 @default.
• W1808253393 cites W2049223762 @default.
• W1808253393 cites W2049265308 @default.
• W1808253393 cites W2050717908 @default.
• W1808253393 cites W2050914105 @default.
• W1808253393 cites W2051051060 @default.
• W1808253393 cites W2051999166 @default.
• W1808253393 cites W2056277685 @default.
• W1808253393 cites W2056728315 @default.

• next